Staar Surgical (STAA) Cash from Investing Activities (2010 - 2026)

Staar Surgical has reported Cash from Investing Activities for 17 years, with the latest figure at $2.1 million in Q2 2026.

• For the quarter ending Q2 2026, Cash from Investing Activities fell 93.93% year-over-year to $2.1 million; the trailing twelve-month figure through Apr 2026 stood at $13.1 million (up 132.79% YoY), and the FY2026 full-year result was $46.3 million, up 178.25% from the prior year.
• Cash from Investing Activities for Q2 2026 stood at $2.1 million, up from -$19.4 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $35.4 million in Q1 2025, with the low at -$101.8 million in Q3 2022.
• Historically, Cash from Investing Activities has averaged -$5.5 million across 5 years, with a median of $2.1 million in 2026.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 3011.79% — and 2023, when it soared 491.22%.
• Staar Surgical's Cash from Investing Activities stood at -$46.7 million in 2022, then surged by 147.95% to $22.4 million in 2023, then plunged by 187.02% to -$19.5 million in 2024, then soared by 127.1% to $5.3 million in 2025, then tumbled by 59.36% to $2.1 million in 2026.
• The last three Cash from Investing Activities figures came in at $2.1 million (Q2 2026), -$19.4 million (Q1 2026), and $5.3 million (Q3 2025), per Business Quant data.